Gauss Surgical Closes $12.6M Series B Financing
Summary
Gauss Surgical, Inc., a Los Altos, CA-based a medical technology company, closed $12.6m Series B financing.In conjunction with the funding, Daniel Galles, a partner at Providence Ventures, and Mike Collett, founder and managing partner of Promus Ventures, will join Gauss’ board of directors.In addition, Dr. Garrett Vygantas, partner at Jump Capital, will join as Board Observer.Led by founder and Chief Executive Officer Siddarth Satish, Gauss Surgical has developed Triton, a platform for real-time monitoring of surgical blood loss, which combines computer vision and machine learning applications, to support surgeons in making better decisions, armed with accurate blood loss assessments.Triton, which has four FDA clearances along with approval for CE Mark, is in clinical use at several health systems in the United States including HackensackUMC, Cedars-Sinai Medical Center, the MemorialCare Health System, UC Irvine Medical Center, and others.